Enzyme-Instructed Assemblies Enable Mitochondria Localization of Histone H2B in Cancer Cells

23 December 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

It is known that a highly dynamic communication among subcellular organelles (e.g., cytosol, endoplasmic reticulum (ER), mitochondria, and nucleus) dictate cellular behaviors. But little information exists on how the inter-organelle crosstalk impacts cancer cells due to the lack of approaches that manipulate inter-organelle communication in cancer cells. We unexpectedly found that a negatively charged, enzyme cleavable peptide enables the trafficking of histone protein (H2B), a nuclear protein, to the mitochondria in cancer cells. The peptide, denoted as MitoFlag, interacts with the nuclear location sequence (NLS) of H2B to block it entering nucleus. A protease on the mitochondria cleaves the Flag from the complex of MitoFlag and H2B to form assemblies that retain H2B on the mitochondria and facilitate the H2B entering mitochondria. Molecular validation of MitoFlag shows that adding NLS, replacing aspartic acid residues by glutamic acid residues, or changing L-aspartic acid to D-aspartic residue abolishes the trafficking of H2B into mitochondria of HeLa cells. As the first example of enzyme-instructed self-assembly (EISA) of a synthetic peptide for trafficking endogenous proteins, this work provides insights for understanding and manipulating inter-organelle communication in cells.

Keywords

Enzyme
Self assembly
peptide
Mitochondria
Histone H2B protein
interorganelle communication

Supplementary materials

Title
Description
Actions
Title
H2B Rev ESI
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.